Skip to main content Skip to navigation Skip to mobile navigation Skip to accessibility tools

Switchboard0151 556 5000

24/7 hotline (treatment side-effects)
The Clatterbridge Cancer Centre NHS Foundation Trust
Private care
Charity
  • Home
  • Patients and visitors
    • Patients and visitors
    • Treatment and care
      • Treatment and care
      • Treatments
      • Cancer types
      • Consultants
      • Your first visit
      • Hospital appointments
      • Video appointments
      • Inpatients
      • Health advice - eating well, exercise and cancer care
        • Health advice - eating well, exercise and cancer care
        • Physical activity and cancer care
        • Eating well and cancer care
      • Clinical trials
      • Visitors
      • Getting here
      • Isle of Man patients
      • Private and international patients
      • Advice and support
        • Advice and support
        • Interpreters and help with additional needs
        • Cancer information and support centres
        • Benefits advice
        • Arts programme
        • Chaplaincy
      • Feedback, compliments and complaints
      • Request your records (subject access requests)
        • Request your records (subject access requests)
        • Request your records - easy-read information
        • Subject Access Request Form
      • Referral and second opinion
      • Patient information leaflets
        • Patient information leaflets
        • Lung cancer nursing team
        • Radiotherapy
        • Contact x-ray brachytherapy for rectal cancer (Papillon)
        • You and your gastrostomy feeding tube
        • Insertion of a rectal spacer for radiotherapy
        • High Dose Rate (HDR) brachytherapy to the vaginal vault
        • Proton beam therapy to the eye
        • High Dose Rate (HDR) brachytherapy to the skin
        • High Dose Rate (HDR) brachytherapy for cancer of the cervix
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy in combination with external beam radiotherpay (EBRT)
        • Immunotherapy
        • Nasogastric tube - Being discharged with a nasogastric tube
        • You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath
        • You and your PICC line
        • Eating well and coping well with side-effects on a vegan diet
        • Low residue diet information
        • Adding extra nourishment to your food when you have diabetes
        • Eating well and coping well with side-effects
        • Proton beam therapy: Frequently asked questions and other useful information
        • Hepato-pancreato-biliary (HPB) nursing and support team
        • Arthralgia
        • Immune-related hepatitis
        • Skin care advice for patients on immunotherapy treatment
        • Infliximab - frequently asked questions
        • Cancer of Unknown Primary
        • Your nasogastric (NG) feeding tube and medication
        • Lymphoedema advice
        • What to do after an extravasation
        • Scalp cooling - a guide for patients
        • Breast cancer nursing team
        • Prostate cancer nursing and support team
        • Skin cancer nursing team
        • Upper gastrointestinal (UGI) nursing and support team
        • Teenage and Young Adult service
        • Choosing a wig
        • Your cancer treatment in your community
        • Liver surveillance service
        • Supported self management and patient-directed open access - MGUS
        • Sick day rules for people on basal bolus or pre-mixed insulin
        • Patient information for referral for consideration of SABR
        • Simple lymphatic drainage - head and neck
        • Advice to patients with a cardiac implantable electronic device – pacemakers or ICDS
        • How can we help? (Holistic Needs Assessment)
        • Pituitary and craniopharyngioma – radiotherapy
        • My Medical Record - information for patients
        • Lenalidomide (Revlimid) switch to generic equivalents
        • Lidocaine 2% mouthwash
      • Communicating with patients
    • Our hospitals
    • Our services
    • Consultants
    • Get involved
  • Research and innovation
    • Research and innovation
    • Research
      • Research
      • Welcome to research
      • Our research
      • Research sponsorship
      • Clinical trials
      • Meet the team
      • Research partnerships
      • Jargon buster
      • Biobank
      • Research Strategy
      • How you can get involved
      • Research passports, honorary research contracts and letters of access
      • Research news
    • Innovation
      • Innovation
      • Welcome to innovation
  • Work with us
    • Work with us
    • Vacancies
    • Recruitment - joining our team
    • Your career: Our recruitment pack
    • Staff benefits: why choose us
      • Staff benefits: why choose us
      • Staff networks
      • Staff Excellence Awards 2023
        • Staff Excellence Awards 2023
        • Staff Excellence Awards 2022
    • Roles and careers we offer
      • Roles and careers we offer
      • Healthcare science
      • Physiotherapy
    • Staff profiles
    • Staff bank
    • Living locally
    • Apprenticeships
    • Work experience
    • Volunteering
    • Get involved
    • Staff privacy notice
  • Professionals
    • Professionals
    • Education and training
      • Education and training
      • Clinical education courses
      • Clinical scientist training
      • Communication skills
      • FRCR Part 2b mock exam
      • Nursing career pathway
        • Nursing career pathway
        • Nursing career pathway and competency framework toolkit
      • Papillon
    • Clinical guidance
      • Clinical guidance
      • Acute oncology (AO) and CUP guidance
      • Immunotherapy guidance
      • Metastatic spinal cord compression (MSCC) guidance
      • Catheter and line care guidance
      • SACT protocols and guidance
        • SACT protocols and guidance
        • All protocols and guidance
        • Breast
        • CNS
        • Gastrointestinal
        • Germ cell
        • Gynaecological
        • Haematology
        • Head and neck
        • Lung
        • Miscellaneous
        • Renal
        • Sarcoma
        • Skin
        • Supportive therapies
        • Urology
      • Referring patients
      • Haemato-Oncology (haematology) clinical guidance
    • Work with us
  • About us
    • About us
    • Who we are
    • Vision and strategy
      • Vision and strategy
      • Vision, mission and values
      • Strategies and plans
        • Strategies and plans
        • Five Year Strategic Plan
        • Green Plan
        • Innovation Strategy
        • People Commitment
        • Patient Experience Commitment
        • Research Strategy
        • Quality Improvement and Learning Strategy
    • How we're run
      • How we're run
      • Trust Board
        • Trust Board
        • Trust Board meetings and papers
      • Procurement
      • Council of Governors
        • Council of Governors
        • Our governors
      • Membership of our Trust
    • Who we work with
    • How we're doing
      • How we're doing
      • Our reports and accounts
      • Care Quality Commission
      • Equality, diversity and inclusion
      • Achievements and accreditations
    • Our services
    • Our history
    • Publications and documents
    • Freedom of Information (FOI)
    • News
    • Get involved
  • Contact us
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn

All protocols and guidance

You are here:

  1. Home
  2. Professionals
  3. Clinical guidance
  4. SACT protocols and guidance
  5. All protocols and guidance

You are here:

  1. Professionals - SACT protocols
  2. Lung
Thumbnail Title
PDF file icon Tepotinib Advanced NSCLC with MET exon 14 skipping alterations
PDF file icon Osimertinib-NSCLC T790M Mutation Protocol V1.3
PDF file icon Afatinib Non Small Cell Lung Cancer Protocol V1.1
PDF file icon Alectinib Protocol V1.1
PDF file icon Atezolizumab NSCLC
PDF file icon Atezolizumab, Carboplatin and Etoposide (Oral and IV regimens) Small Cell Lung Cancer (SCLC)
PDF file icon Brigatinib Non-small Cell Lung Cancer Protocol V1.2
PDF file icon Carboplatin & Pemetrexed Non-Small Cell Lung Cancer Protocol V1.0
PDF file icon Carboplatin Etoposide (Oral and IV regimens) Small Cell Carcinoma
PDF file icon Carboplatin with Pemetrexed & Pembrolizumab Non Squamous NSCLC Protocol V1.2
PDF file icon Ceritinib Non Small Cell Lung Cancer Protocol V2.1
PDF file icon Cisplatin & Gemcitabine Non Small Cell Lung Cancer Protocol V1.0
PDF file icon Cisplatin & Pemetrexed Non-Small Cell Lung Cancer Protocol V1.1
PDF file icon Cisplatin & Vinorelbine Chemo-radiation 42 day Regimen Protocol V1.0
PDF file icon Cisplatin & Vinorelbine Chemo-radiation Regimen NSCLC Protocol V1.0
PDF file icon Cisplatin & Vinorelbine Non Small Cell Lung Cancer Protocol V1.0
PDF file icon Cisplatin with Pemetrexed & Pembrolizumab Non squamous NSCLC Protocol V1.2
PDF file icon Cisplatin - Etoposide (Oral and IV Regimes) Protocol V1.1
PDF file icon Crizotinib Protocol V1.2
PDF file icon Cyclophosphamide, Doxorubicin & Vincristine (CAV) Protocol
  • ← Previous page
  • Page 1
  • Page 2
  • Page 3
  • Next page→

More in this section...

Breast

CNS

Gastrointestinal

Germ cell

Gynaecological

Haematology

Head and neck

Lung

Miscellaneous

Renal

Sarcoma

Skin

Supportive therapies

Urology

Last updated 11th March 2024

  • Aintree
    Telephone: 0151 556 5958
  • Liverpool
    Telephone: 0151 556 5000
  • Wirral
    Telephone: 0151 556 5000
  • Other clinics
    Telephone: 0151 556 5000
  • Paddington
    Telephone: 0151 556 5000
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn
  • Compliments and complaints
  • Vacancies
  • Accessibility statement
  • Privacy
  • Freedom of information
  • CQC rating

Accessibility tools

Text size:
Contrast:

Created by Frank Ltd.

Return to header
Last accessibility toolbar action: none available